As of Feb 05
| +0.0098 / +2.45%|
The 5 analysts offering 12-month price forecasts for Mast Therapeutics Inc have a median target of 3.00, with a high estimate of 5.00 and a low estimate of 1.00. The median estimate represents a +632.24% increase from the last price of 0.41.
The current consensus among 6 polled investment analysts is to Buy stock in Mast Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.